Danlag, Mark Ejay .

HRN: 28-36-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/06/2026
01/13/2026
IV
685 Mg
Q6hrs
Pcap C
Waiting Final Action 
01/10/2026
CEFTRIAXONE 1G (VIAL)
01/10/2026
01/17/2026
IV
1.1g
OD
Pneumonia
Checking Initial Appropriateness 
01/11/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/11/2026
01/15/2026
PO
3.5ml
OD
PCAP-C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: